Michael Wacker
15Patents
4h-index
6Co-inventors
53Inventor score
Filing activity: Mar 15, 1999 → Dec 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6497442B1 | On-site media and communications trailer | Performing Operations; Transporting | 31 | Expired |
| US6209939A | On-site media trailer | Performing Operations; Transporting | 24 | Expired |
| US8703471B2 | System and method for the production of recombinant glycosylated proteins in a prokaryotic host | Chemistry; Metallurgy | 22 | Active |
| US8871491B2 | Capsular gram-positive bacteria bioconjugate vaccines | Emerging Cross-Sectional Technologies | 10 | Active |
| US8895014B2 | Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells | Emerging Cross-Sectional Technologies | 4 | Active |
| US9585950B2 | Capsular gram-positive bacteria bioconjugate vaccines | Emerging Cross-Sectional Technologies | 4 | Active |
| US10195262B2 | Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli | Emerging Cross-Sectional Technologies | 2 | Active |
| US8846342B2 | Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells | Emerging Cross-Sectional Technologies | 1 | Active |
| US12398380B2 | Methods of host cell modification | Chemistry; Metallurgy | 0 | Active |
| US10835592B2 | Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US11220676B2 | Methods of host cell modification | Emerging Cross-Sectional Technologies | 0 | Active |
| US10973901B2 | Production of recombinant vaccine in E. coli by enzymatic conjugation | Emerging Cross-Sectional Technologies | 0 | Active |
| US9764018B2 | Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US10307473B2 | Capsular gram-positive bacteria bioconjugate vaccines | Emerging Cross-Sectional Technologies | 0 | Active |
| US11944675B2 | Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.